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AIM
1. To study the clinical profile of pediatric HIV infection in the age group of 18 
month to 12 years 
2. To correlate the clinical features with the CD4 count. 
STUDY JUSTIFICATION
HIV  /  AIDS  is  a  global  epidemic  now  and  it  has  the  potential  to  affect  all 
countries and all population2.
Approximately 50% of new infection occur in the young adults <25 years2 and if 
they  left  untreated,  will  die  within  10  years  of  contracting  the  infection.  Hence  it 
becomes very important to identity these patients and put them under regular followup 
and to start ART, if necessary at the earliest.
India  accounts  for  high  global  HIV  burden  and  Tamilnadu  comes  under 
Intermediate prevalent zone with antental mothers with HIV infection <1% with  STI > 
20%7.
As  per  the  sentinel  surveillance  report  by  NACO  for  the  year  2006-2007, 
incidence  of HIV infection in antenatal mothers in Salem is 4% and hence mother to 
childhood transmission increases multifold7.
This study is aimed to identity the early clinical features of HIV infection. Thus 
by knowing the  clinical  spectrum of  HIV infection  in  our  region,  screening can  be 
intensified on the suspected children and early diagnosis can be made, which will help in 
early management and  in decreasing the incidence of HIV related morbidity 
MATERIALS AND METHODS
Nature of 
Study
:
Descriptive study
Study 
population
: 100  children  who  were  registered  in 
ART centre over a period of 1 year were 
taken
Period and 
Place of study
: This study was conducted over a period 
of  1  year  from  Oct  2007-Oct  2008  at 
Govt. Mohan Kumaramangalam Medical 
College Hospital, Salem.
Inclusion 
Criteria
: Children  who  got  registered  in  ART 
centre in the age group of 18 months to 
12 years, whose diagnosis in confirmed 
by  Rapid  antigen  tests  or  ELISA were 
included
Exclusion 
Criteria
: Children <18 months were not taken as 
the facility for making diagnosis by PCR 
was not available in our centre.
A special proforma was designed to record the following information:
 Demographic data
 History at presentation
 Clinical findings
 Nutritional status
 Developmental History
 Stage of disease
 Parental and sibling status
 Mode of transmission
Informed  consent  was  obtained  from the  parent  /  guardian  for  registering  the 
above data in prescribed proforma.
Pulmonary Tuberculosis was confirmed by doing;
 Complete Blood Count
 CXR
 Sputum examination / Resting Gastric Juice analysis
 Non responsiveness to conventional antibiotics
 History of contact
 Response to ATT
TB lymphadenitis was diagnosed based on Blood complete FNAC report.
 HIV encephalopathy was diagnosed based on clinical features, CSF analysis, Neruo 
imaging. 
 Diagnosis  made  on  the  skin  lesions  which  is  found  to  be  one  of  the  common 
manifestation were confirmed by Department of dermatology.
 IAP classification (for weight) and Mclaren’s classification (for height) were used to 
classify Nutritional status.
INTRODUCTION
EPIDEMIOLOGY
World over 38.6 million people are living with HIV, follow of which  2.3 million 
i.e. 5.9% are children <15 years of age1.
 In 2007 – 4,20,000 children were newly infected.
 Estimated children living with HIV / AIDS in India is 0.17 – 0.24 million (3.5-5% 
of people with HIV).
 Prevalence of HIV in pregnant mother is 0.6% - 0.7% (National).
 Adult prevalence is 0.36% (0.43% males and 0.29% females)
 Children account for 18% of total deaths due in AIDS i.e. 1 in every six AIDS 
death every year is a child, but they are < 1 in every twenty five persons getting 
treatment.
India is divided into 3 (three) zones of prevalence.
(a) High Prevalence States :
(HIV Prevalence in AN mother > 1%)
Maharastra, Karnataka, Andrapradesh, Manipur, Nagaland. Average Prevalence is 
1.6%
(b) Intermediate prevalence (on medium prevalence states):
(AN prevalence < 1% High risk population in STI clinics >20%)
Tamilnadu, Gujarat, West Bengal. Average prevalence is 0.5% in AN mothers.
(c) Low prevalence States
(AN HIV prevalence < 1% High risk population is STI clinics <20%)
Rest of the states. Average prevalence is 0.2% in AN mothers.
In developing countries 95% of cases in children are due to vertical transmission 
from infected parents. Approximately 15-30% in non breast feeding population. 30-45% 
in Breast feeding population.
(Breast feeding increases the risk by 5-20%)
In the absence of effective coverage of PMTCT measures, 30% of the exposed 
babies get infected at birth.
The risk of transmission can be reduced to < 2% by
a) ARV prophylaxis to women during pregnancy / labour and to the infant in first 
week.
b) Elective Caesarean Section – prior to onset of labour and rupture of membranes)
c) Complete avoidance of Breast feeding.
TRANSMISSION AND PATHOGENESIS OF PAEDIATRIC HIV DISEASE
HIV Virus
• RNA Virus
• Belongs to the class of Retroviruses in the subgroup of Lentiruses.
• Two types HIV-1 and HIV-2
- Both can cause clinically indistinguishable AIDS
- HIV-1 is predominant virus world wide.
- HIV-2 is less easily transmitted, period of initial infection and illness is longer. 
This type is concentrated in West Africa.
• HIV-1 can be divided into three groups
a) M (Major Group) – 90% of HIV belong to this category
b) O (Outlier Group) – Restricted the West Central Africa.
c) N (New Group) – Discovered in 1998 in Cameroon extremely rare.
Group M – has 9 clinically distinct subtypes:
 A, B, C, D, F, G, H, J, K.  HIV-1 Group M (C) is prevalent in India.
HIV STRUCTURE:
HIV virus is surrounded by a coat of Fatty material and forms  Viral envelope. 
gp120 / gp41 are projecting from the surface. Just below the envelope is a layer called 
Matrix made from protein P17. Viral core or capsid is bullet – shaped and is made of 
protein P24.
Inside the core are three enzymes. Reverse Transnsciptase, Integrase, Protease and two 
identical strands of HIV RNA.
Transmission of HIV:
- HIV present virtually in all body fluids of affected individual. 
- High concentration of  free  HIV virus /  HIV infected cells  present  in seminal, 
vaginal, cervical secretions (Genital fluids) and blood.
- Saliva has low HIV (< 1 particle/ml) with non specific inhibitory substances like 
fibroblasts and glycoprotein.
- Urine,  Sweat,  Amniotic  fluid,  Synovial  fluid,  faeces,  tears  have  zero  to  few 
particles.
Route of transmission
- Vertical transmission
- Blood and Blood products
- Unprotected sexual contact.
Rate of Transmission
A) Vertical (> 90%)
Without intervention, overall transmission rate is
16-20% in developed countries.
25-45% in developing countries.
Due to
a) Breast feeding
b) High incidence of prematurity
c) Under nutrition among mothers
Estimated risk of MTCT
Age Risk of transmission
0-14 weeks 1%
14-36 weeks 4%
30 weeks till labour 12%
During labour 8%
0-6 months (Post Natal) 7%
6-24 months 3%
Overall risk of transmission 
without breast feeding 20-25%
Overall risk of transmission 
with breast feeding till 6 
months
25-30%
Overall risk of transmission 
with breast feeding upto 24 
months
30-35%
Timing and Mechanism of transmission
Transmission occurs through transplacental transfer of virus (micro-circulation) 
during pregnancy,  at  the time of labour and delivery – due to exposure of skin and 
mucus membrane to infected blood and cervico-vaginal secretion.
 
Transmission through breast feeding 70% occurring during first  4-6 months of 
feeding and longer the duration, higher the risk. Mixed feeding increases the risk.
Risk factors for Vertical Transmission:
Pregnancy Labour & Delivery Breast Feeding
High viral load High viral load High viral load
Placental 
infection
Rupture of members for 
more than 4 hours
Duration of breast 
feeding
STI
Invasive techniques that 
increase contact with 
mother’s infected blood 
(Episiotomy, Fetal scalp 
monitoring)
Breast abscess, 
fissures, mastitis
Maternal 
Malnutrition
First infant in multiple birth
Poor maternal 
nutritional status
Maternal 
bleeding
Acute chorioaminionits 
Oral disease in 
infant (thrush or 
Sores)
Vaginal delivery
Prematurity
B) Blood Borne Infections:
3-6% of Paediatric infections.
C) Sexual Transmission:
- Uncommon is paediatric population
- Happen from sexual abuse
- Receptive partners are at a high risk than  ‘insertive’ patients
- Viral load determines the risks.
Risk of Transmission of HIV with different Routes
Sl. 
N
o.
Route of Exposure Transmission rate
% of HIV infected 
individual who have 
acquired infection 
through this route
World India
1. Blood transfusion 90-95% 5% 7.05%
2. Perinatal 20-40% 10% 11%
3. Sexual Lute course 0.1-1% 75% 74.15%
Vaginal 60%
Anal 15%
4. IV drug use 0.5-1% 10% 7.3%
5. Needle Stick exposure <0.5% 0.1% 0%
6. Others 10.92%
PATHOGENESIS
HIV
- Infection leads to progressive depletion of CD4 cells and immune suppression.
- Infects cells other than T-cells, which express CD4 
o Monocytes and tissue Macro phages
o Microglial cells of brain
o Hofbauer cells of placenta.
o Dendritic (Follicular dendritic cells in LN Langerhan cells in skin)
- Lymphonodes are the major reservoirs in asymptomatic HIV individuals.
HIV Replication
Can replicate only inside Human cells.
HIV attaches to CD4 through gp 120 and gp 41
Contents of the HIV particulars are released to the cell leaving the envelope.
HIV RT converts RNA to DNA.
This viral DNA spliced into Human DNA after curing the nutrition by HIV enzyme 
Integrase.
(This integrated HIV DNA – Provirus)
Provirus forms Messenger RNA
New HIV proteins are produced
Enzyme protease chops long strands of protein into smaller pieces forms new viral 
particles
Released from the cell
Primary HIV Infection
Via Mucosal exposure Via infected blood and blood products
Mucosal dendritic cells bind 
HIV Envelope gp 120 Directly go to lymph nodes
And lymphoid tissue.
After processing, transport and
present HIV to cells expressing
CD4 molecules.
Then transport to regional LN and other 
Lymphoid tissues, where intense replication
Occurs
When replication reaches critical level, burst of Viremia followed by rapid 
discrimination occur (usually 3-6 weeks after infection)
Flu like illness – Acute HIV Infection
(observed is 50% of infected)
Clinically : Fever, rash, arthralgia, Lymphadenopathy
Lab : Significant fall in CD4, High Viral load 106-107 copies/ml.
CD8 plays important role in containing infection Neutralizing antibodies appearing later 
help in continuing the suppression of infection.
CLINICAL LATENCY
Latent Period / Clinic and Persistent Infection
- Acute viral disease disappear.
- Free and cell associated virus decreases.
- CD4 near normal.
- Neutralizing virus specific antibodies increases.
- Chronic and persistent infection present inspite of intense cellular and humoral 
immune response.
- These  high  antibodies  are  not  protective  and  do  not  interfere  with  cell-cell 
transmission
- This period lasts for 8-10 years in adults and much less for children.
Advanced HIV Disease
- Reemergence  of  the  virus  is  peripheral  blood  and  lymphnodes.  Progressive 
decline in CD4 cell population. Loss of CD8 cell anti-HIV activity.
- Results in 
o Profound immune suppression.
o End organ dysfunction
o HIV associated opportunistic infections
o Malignancies
o Change  in  viral  phenotype  from  Non  syncytium  inducing  (NSI)  to 
Syncytium inducing (SI) virus.
Natural History of Pathogenesis of HIV-2
(i) Fewer immunological disturbance
(ii) Low transmissibility
(iii) Longer incubation period
(iv) Lower rate of vertical transmission
(v) Lower plasma TNF α
(vi) Lower Viral load
(vii) Lower level of Proviral DNA in circulating lymphocytes.
HIV-2 has a natural resistance to NNRTI – ARD, therefore not recommended
Natural History and Pathogenesis of HIV-1 (in Children)
Three Patterns 
(Before era of HAART)
Have detectable virus in 
Plasma in first 48 hours 
of life
Minimal or no 
progression of diseases 
with Normal CD4 count
Medial Survival is 6 
years
60-80% of perinatally 
infected Newborn fall in 
this group
Constitutes 15-25% of 
HIV infected Newborns Constitutes < 5%
Rapid Progressors
Long term survivorsSlow Progressors
Infected during breast 
feedingInfected Perinatally
months; Infected in 
utero
CLASSIFICATION AND CLINICAL FEATURES
Two Classification
i) CDC Classification – Symptomatic HIV divided into four categories based on 
the severity of the symptom.
ii) WHO – Clinical classification immunological classification based on CD4.
Revised  WHO  Clinical  Staging  of  HIV/AIDS  for  Infants  and  Children  with 
Confirmed HIV Infection (> 18 months of age – HIV Antibody Test Positive, < 18 
months of age – Virologic Test Positive)
Clinical Stage 1 (Aysmptomatic)
 Asymptomatic
 Persistent generalized lymphadenopathy
Clinical Stage 2 (Mild)
 Unexplained persistent hepatosplenomegaly
 Papular pruritic eruptions
 Extensive wart virus infection
 Extensive molluscum contagiosum
 Fungal nail infections
 Recurrent oral ulcerations
 Unexplained persistent parotid enlargement
 Lineal gingival erythema
 Herpes zoster
 Recurrent or chronic upper respiratory tract infections (otitis media,  otorrhoea, 
sinusitis, tonsillitis)
Clinical Stage 3 (Advanced)
 Unexplained  moderated  malnutrition  not  adequately  responding  to  standard 
therapy
 Unexplained persistent diarrhea (14 days or more)
 Unexplained persistent fever (above 37.5° C intermittent or constant, for longer 
than one month)
 Persistent oral candidiasis (after first 6-8 weeks of life)
 Oral hairy leukoplakia
 Acute necrotizing ulcerative gingivitis/periodontitis
 Lymph node TB
 Pulmonary TB
 Severe recurrent bacterial pneumonia
 Symptomatic lymphoid interstitial pneumonitis
 Chronic HIV-associated lung disease including bronchiectasis
 Unexplained  anemia  (<8g/dl),  neutropenia  (<0.5x109/L3)  or  chronic 
thrombocytopenia (<50 x 109/L3)
Clinical Stage 4 (Severe)
 Unexplained severe wasting,  stunting or  severe malnutrition not  responding to 
standard therapy
 Pneumocystis pneumonia
 Recurrent severe bacterial infections (e.g. empyema, pyomyositis, bone or joint 
infection, meningitis, but excluding pneumonia)
 Chronic  herpes  simplex  infection;  (orolabial  or  cutaneous  of  more  than  one 
month’s duration or visceral at any site)
 Extrapumonary TB
 Kaposi sarcoma
 Oesophageal candidiasis (or cnadidiasis of trachea, bronchi or lungs)
 Central nervous system toxoplasmosis (after one month of life)
 HIV encephalopathy
 Cytomegalovirus infection:  retinitis  or  CMV infection affecting another  organ, 
with onset at age over 1 month.
 Extrapulmonary cryptococcosis (including meningitis)
 Disseminated endemic mycosis(extrapulmonary histoplasmosis, coccidiomycosis)
 Chronic cryptosporidiosis
 Chronic isosporiasis
 Disseminated non-tuberculous mycobacteria infection
 Cerebral or B cell non-Hodgkin lymphoma
 Progressive multifocal leukoencephalopathy
 Symptomatic HIV – associated nephropathy or HIV- associated cardiomyopathy.
DIFFERENCES IN PEDIATRIC AND ADULT HIV- INFECTION
 Overall progression of disease is more rapid in children
 Immune system is more immature with higher CD4+ counts
 Recurrent invasive bacterial infections are more common in children.
 Disseminated  CMV,  Candida,  Herpes  Simplex  and  Varicella  Zoster  are  more 
common.
 LIP occur almost exclusively in children.
 CNS infections are common.
 Peripheral neuropathy, Myopathy are rare in children.
 Kaposi Sarcoma is hardly ever reported.
The manifestations of the infection vary widely among infants, young children 
and adolescents. Most infected children are asymptomatic and do not have any abnormal 
findings on clinical examination at birth. The initial manifestations of the disease are 
mild and non-specific,  these include lymphadenopathy, chronic or recurrent diarrhea, 
failure to thrive, wasting and oral trush. In contrast, the presentation in adolescents is 
similar to that in adults.
Common Manifestations of HIV-infection in Children
Manifestations MORE 
Commonly Encountered
Manifestations LESS Commonly 
Encountered
Lymphoid Interstitial 
Pneumonitis (LIP) Chronic 
Parotid Swelling
Opportunistic Infections:
• Tuberclosis
• Pneumocystis Carinii 
Pneumonia
•  Serious Recurrent 
Bacterial Infections
HIV Encephalopathy
Kaposi's Sarcoma 
Malignancies: CNS lymphoma 
Opportunistic Infections:
• Cryptococcosis,
• Histoplamosis,
• Toxoplasmosis,
Disseminated Mycobacterium 
Avium Complex (MAC) 
infection.
CLINICAL MANIFESTATIONS 
Failure to Thrive
Failure to thrive is a very common feature of Pediatric HIV-infection in India. 
HIV-infection has an adverse effect on the growth of infected children and parameters 
such as weight, height and head circumference show deviation from the normal. The 
retardation of growth can be seen as early as 4-6 months of age in perinatally infected 
children.  The  factors  that  seem to  contribute  to  growth  retardation  in  HIV-infected 
children  are  many  (i.e.  low  birth  weight,  decreased  energy  intake,  diarrhea, 
malabsorption,  chronic  diseases  of  the  heart,  kidney  and  lungs,  micronutrient 
deficiencies, neuroendocrine abnormalities and repeated episodes of infection). Infants 
born to HIV-infected mothers have early growth delay, which have been correlated with 
high  viral  load  in  mothers.  Length/height  and  weight  are  two  anthropometrical 
parameters  that  represent  growth  in  children.  Therefore  it  is  necessary  that  these 
parameters  be  regularly  monitored  in  children,  so  that  the  earliest  sign  of  growth 
retardation can be detected.
Hepatomegaly
Hepatomegaly is a common manifestation of pediatric HIV disease. It is likely to 
be caused by the replication of the virus in the reticuloendothelial tissue of the liver. 
Development of hepatomegaly within 3 months of age (in perinatally acquired HlV-
infection)  has  prognostic  significance  since  it  is  known to  be  associated  with  rapid 
progression of the disease. Malnutrition, fatty liver, steatosis, drug administration, CMV 
infection and malignancy can be some of the other causes for hepatomegaly in the HIV-
infected children. Abnormal liver functions are common. Co-infection of Hepatitis C 
with HIV is well known.
Lymphadenopathy
HIV, after initial viraemia, gets trapped in the lymph nodes. The virus resides in 
the lymph nodes and also multiplies there. The replication of HIV in the nodes is the 
primary cause of lymphadenopathy. Other important conditions commonly associated 
with HIV-infection that can give rise to generalized lymphadenopathy in HIV-infected 
children include tuberculosis, disseminated infections with other mycobacterial species, 
viral infections with CMV, Epstein-Barr virus (EBV) and malignancies like Iymphoma 
and Lymphosarcoma.
Chronic Diarrhoea
Diarrhoea is a very common clinical manifestation of HIV-infected infants and 
children in developing countries. As with many other symptoms of HIV- infection, the 
underlying  mechanisms  for  diarrhea  are  many.  These  include  infections,  other 
inflammatory processes and malabsorption of carbohydrate and fats. HIV is presumed to 
be responsible for diarrhoea if one fails to isolate any organism. It is believed that HIV 
replication  in  the  intestinal  mucosa  can  lead  to  diarrhoea  itself  leading  to  HIV 
entropathy. Other causes of chronic diarrhea are opportunistic enteric infections with 
common  organisms  like  Candida,  Cryptosporidium,  Cytomegalovirus,  Giardia, 
Isosporabelli and Salmonella. These result in a dysfunctional immunity at the lamina 
propria  of  the  gut  leading  to  decreased  secretary  IgA,  the  principal  protective 
immunoglobulin. The reduced helper T-cel! function results in the decrease of mucosal 
immune system of the gut as result of persistent infection, leading to prolonged diarrhea 
with malabsorption and malnutrition.
Infectious  Agents  Implicated  as  The  Causes  Of  Diarrhoea  In  HIV-Infected 
Children
Agent Organisms
Viruses Rotavirus, Cytomegalovirus, Adenovirus, HIV, HSV
Bacteria Shigella, Camylobacter, E. coli, MAC, Salmonella
Protozoa Cryptosporidium,  parvum,  Isosporabelli, 
Microsporidia,  Entemoeba  histolytica,  Giardia 
Lamablia
Fungi Histoplasma
Parotitis
Parotitis  occurs  as  recurrent  or  chronic  hypertrophic  parotitis.  The  parotid 
swelling evolves gradually in-patients with HIV disease. It may be due to the direct 
infection of the parotid gland by HIV or due to lymphocytic infiltration of the gland. 
The swelling may be unilateral or bilateral but is classically painless and recurrent.
Skin Manifestations
HIV disease in children is associated with a number of skin manifestations. These 
can be due to infectious or non-infectious causes. Viral, bacterial and fungal infections 
have been very frequently reported in HIV-infected children. These usually tend to be 
more severe and resistant to therapy. Common skin diseases may present with unusual 
skin lesions such as Norwegian Scabies, disseminated, confluent and large lesions of 
Molluscum contagiosum.
SKIN MANIFESTATIONS IN HIV-INFECTED CHILDREN
Infectious Disorders and lesions
Non -  Infectious  Disorders  and 
lesions
Viral Infections:
Herpes simplex, Herpes zoster,
Molluscum contagiosum, Warts
Seborrheic  dermatitis,  Atopic 
dermatitis  CMV,  Generalized 
dermatitis,  Nutritional 
Deficiency
Fungal Infections:
Candida, Tinea, Onchomycosis
Eczema,  Psoriasis,  Drug 
eruptions
Bacterial: Impetigo Vasculties
Other: Scabies Alopecia
Oralcandidiasis
Oral Candidiasis is the most common form of fungal infection encountered with 
HIV-infected  children.  It  progresses  to  involve  the  esophagus  in  20% of  cases  and 
denotes significantly impaired T-cell function, presenting with symptoms as anorexia, 
dysphasia,  vomiting  and  fever.  Other  oral  manifestations  included  in  differential 
diagnosis  are  gingivostomatis,  apthous  ulcer,  herpes  labial  peritonitis  and oral  hairy 
leuco plakia.
Hematological Abnormalities
Pediatric  HIV disease  is  associated  with  different  hematological  abnormalities 
presenting as pallor, Neutropenia, Lymphopenia, Thrombocytopenia and Eosinophilia. 
Thrombocytopenia can be present with petechiae and ecchymosis and may be diagnosed 
as immune Thrombocytopenia.  Alteration of  hematological  profile occurs  due to the 
virus  itself,  opportunistic  infections,  drugs side effects  or  antibody mediated cellular 
destruction.
Hematological 
Abnormality Mechanisms Responsible
Anemia
Auto-immune antibodies that cause destruction of 
erythrocytes;  Suppression of  the bone marrow by 
drugs used in the treatment of HIV-infection (e.g. 
AZT) or of associated infections (i.e. ganciclovir, 
co-trimoxazole); Nutritional deficiency (folic acid, 
Vitamin B12, micro-nutrients)
Thrombocytope
nia
Immune-mediated  destruction  of  platelets, 
Nutritional  deficiency  (i.e.  Vitamin  B12 
deficiency)
Neutropenia Immune-mediated destruction of leukocytes
Lymphopenia
Bone marrow suppression due to altered cytokine 
production,  CD4+  apoptosis  induced  by  HIV 
replication
Eosinophilia Shifting  of  immune  response  from  Th1  toTh2 cytokine profile
Cardiac Manifestations
The perinatally infected children do not have a high risk of developing congenital 
cardiac malformations However, cardiovascular diseases do seem to develop in HIV-
infected  children,  and they  are  often  clinically  silent.  The  cardiac  manifestations  of 
diseases  noted  in  HIV-infected  children  include  cardiomegaly,  congestive  cardiac 
failure,  non-bacterial  thrombotic  endocarditis,  cardiomyopathy,  pericardial  effusion, 
cardiac  tamponade,  conduction  disturbances  and  sudden  death.  Cardiomyopathy  is 
frequently  present  in-patients  with  encephalopathy.  The  factors  that  have  been 
implicated  in  the  causes  of  cardiomyopathy  include  primary  HIV disease,  immune-
mediated reactions, intercurrent infections and drug-toxicity. Cardiomyopathy decreases 
the survival rates and is one of the clinical indicators of starting ARV drugs.
Neurological Manifestations
Primary  CNS infection  by  HIV is  quite  common as  it  is  a  neurotropic  virus. 
Neuronal  damage  is  mediated  via  astrocytes  and  neurotoxic  cytokines.  Neuronal 
dysfunctions  through  loss  of  supporting  growth  factors,  excitotoxicity  due  to 
dysregulation  of  neurotransmitter  re-uptake  and  increased  permeability  of  the  blood 
brain barrier, permit further seeding of the virus.
Two forms  of  Encephalopathy  exist  -  Progressive  and Static.  HIV leads  to  a 
myriad of CNS problems of varied etiology, that are both infectious and non-infectious.
HIV Encephalopathy  can  cause  developmental  delay,  with slow attainment  of 
skills or regression of milestones. Developmental delay in HIV-infected children that 
begins  in  infancy  can  also  be  due  to  congenital  opportunistic  infections  such  as 
Toxoplasmosis, CMV or Rubella infection rather than due to HIV-infection alone. It 
should  also  be  appreciated  that,  HIV-infected  infants  are  exposed  to  additional  risk 
factors such as low birth weight, poor prenatal care, maternal illness, drug abuse and 
maternal death that can contribute to developmental delay. The developmental delay is 
more pronounced in the areas of gross motor, fine motor and language skills.
HIV Encephalopathy  can  also  have  manifestations  such  as  loss  of  previously 
acquired  milestones,  cognitive  impairment,  neuropsychiatric  problems,  weakness, 
spasticity  hyperreflexia,  abnormal  extra-pyramidal  signs  and  cerebellar  dysfunction. 
Problems  such  as  learning  disorders,  memory  and  perception  deficits  have  been 
described in asymptomatic or mildly symptomatic HIV-infected children as well. Distal 
peripheral neuropathy is a rare and recently described manifestation of HIV-Infection in 
children  that  is  present  with distal  parasthesiae  or  pain,  diminished ankle  jerks  and 
diminished  vibration  sense.  The  symptoms  are  usually  mild  and  are  chronic  or 
fluctuating.  Emotional  liability,  hyperactivity  and  lethargy  are  late  signs  of 
encephalopathy. HIV Encephalopathy usually manifests in the presence of significant 
immunosuppression  and  features  of  HIV  disease  such  as  Hepatosplenomegaly  and 
Lymphadenopathy are usually present. It carries a poor prognosis. It may be emphasized 
that neurological manifestations like convulsions and alteration of sensorium can also be 
due  to  opportunistic  infections  that  occur  with  greater  frequency  in  these  children. 
Tuberculous  meningitis.  Cryptococcal  meningitis,  pyogenic  meningitis  and  CNS 
toxoplasmosis can give rise to neurological manifestations in H!V-infected children.
According to the CDC revised system, the diagnosis of Encephalopathy requires 
one  of  the  following  progressive findings to be present for at  least 2 months  in the 
absence of other identifiable causes:
• Failure to attain or loss of development milestones or loss of intellectual ability, 
verified by standard developmental scale or neuropsychological tests.
• Impaired  brain  growth  or  microcephaly  demonstrated  by  head 
circumference measurements or brain atrophy demonstrated by CT or MRI, with 
serial imaging required in children less than 2 years of age.
• Acquired symmetric motor deficit manifested by  two or more of the following 
paresis, pathological reflexes, ataxia or gait disturbances.
• CT  may  show  evidence  of  cortical  atrophy,  prominent  sulci,  enlarged 
ventricles  and  decreased  attenuation  of  the  white  matter  suggestive  of 
progressive multifocal leucoencephalopathy.
Nephropathy
The proportion of HIV-infected children who have nephropathy is variable and 
is  more  in  adolescent.  The  manifestations  of  renal  disease  associated  with  AIDS 
include  proteinuria,  hematuria.  hypertension,  renal  tubular  acidosis,  acute  renal 
failure and progression to end-stage renal disease. In the initial stages, the patient could 
be  asymptomatic,  although  laboratory  evidence  of  nephropathy  can  be  found  on 
investigations. Histological changes in AIDS nephropathy reveal focal segmental 
glomerulosclerrosis, minimal lesion  glomerulonephritis,  IgA  nephropathy. 
Nephropathy may be due to direct infection of the virus, immune  complex mediated 
vasculitis, or as a result of various opportunistic infections or drugs.
Respiratory Manifestations
Lymphoid Interstitial  Pneumonitis  (LIP) and Pulmonary  Lymphoid Hyperplasis 
are  the  main  presentations  of  the  respiratory  system  involvement.  The  clinical 
presentation of these disorders are usually insidious.  Cough and Tachypnea are early 
clinical features, followed by Dysprea at rest and development  of clubbing. There 
are often no findings in the  chest unless, recurrent bacterial infections have  led to 
bronchiectasis.  Hepatosplenomegaly,  lymphadenopathy  and  parotid  swelling  are 
the  commonly associated findings.  The findings of diffuse  bilateral  reticulondular or 
interstitial infiltrates on chest radiograph ortomogram support the diagnosis of LIP. The 
nodules are usually 1-5mm in diameter and hilar lymphadenopathy is frequently present. 
A presumptive  diagnosis is  made on the basis of clinical and  radiological findings. 
However,  one  needs  to  exclude  the  presence  of  opportunistic  bacterial,  viral  and 
mycobacterial  infections  that  can  be  present  with  similar  clinical  and  radiological 
findings.  Definitive  diagnosis  requires  lung  biopsy.  Children  with  LIP  have  an 
increased incidence of pulmonary bacterial infections. 
Tuberculosis  is  the  most  common  opportunistic infection  encountered  in 
children, occurring at a higher CD4 count when the immune-deficiency is comparatively 
less  advanced-  Mycobacterium avium inter  cellular  (MAC) causes  disseminated  and 
usually non-pulmonary disease and is an important cause of morbidity in HIV-infected 
children. A CD4 count <100 cells/mm3 has been recognized as a primary risk factor for 
this  infection.  Respiratory  Viruses  like  Respiratory  syncytial  virus,  Measles, 
Parainfluenza, Influenza,  Adenovirus, Rhinovirus and Coronovirus, cause prolong and 
sever  disease.  Fungal  infections  due  to  Histoplasmosis.  Coccidiodomcosis  and 
aspergillosis present similarly. Pneumocystis Carinii Pneumonia (PCP) causes an acute 
life threatening pneumonitis.
Malignancy
The incidence of malignancy in HIV~infected children is higher than that in the 
general population. However, the type of malignancies associated with childhood AIDS 
(Non-Hodgkin's lymphoma, leiomyomas and leiomyosarcomas and leukemia) is much 
different  from  that  associated  with  adult  HIV  disease.  The  Kaposi's  sarcoma,  a 
commonly encountered malignancy in adult HIV disease features is rare in children
Prognostic Indicators
In  underdeveloped  countries  the  age  at  diagnosis  and  the  type  of  clinical 
presentation  are  the  only  clinical  factors  related  to  prognosis.  Infants  who  develop 
symptoms in the first year of life manifest the fastest progression of illness with worst 
outcome.  Similarly,  the  occurrence  of  opportunistic  infections,  progressive 
encephalopathy or hypogammaglobulinemia at any age often carries a poor prognosis. In 
contrast,  generalized  lymphadenopathy,  hepatosplenomegaly,  parotitis  are  associated 
with a more favorable outcome.
Viral load is the most important prognostic marker of the risk of progression. But 
the availability and the cost are the constraints. It is predicted that a favorable clinical 
outcome is most likely if virus replication is maximally suppressed before the immune 
system is irreversibly damaged.
OPPORTUNISTIC INFECTIONS IN HIV / AIDS 
Pneumocystis carinii (Jiroveci) Pneumonia
PCP is the most common OI associated with HIV in children and thus, it is also 
known as “AIDS pneumonia”.  It  is  an infection of early infancy and predominantly 
occurs at the age of 3-6 months.
P.  Carinii,  a  protozoan,  is  closely  related  to  fungi.  PCP  occurring  in 
immunodeficient  HIV – infected infants is likely to represent primary infection.  The 
reservoir  and  the  mechanism of  transmission  of  infection  remain  obscure.  P.Carinii 
establishes  as  an  extra-cellular  parasite.  Interstitial  edema,  hyaline  membrances  and 
proliferating  organisms  fill  the  air  spaces,  resulting  in  progressive  hypoxemia  and 
respiratory failure.
Children with PCP often present with a tetrad of Tachypnea. Dyspnoea, cough 
and fever. Physical examination reveals Tachycardia, respiratory distress, accelerating 
Tachpnea  and  diffuse  retractions.  Auscultation  does  not  reveal  any  characteristic 
findings. ABG shows changes of hypoxemia, and respiratory failure.
The diagnosis can be confirmed by Wright-Giemsa staining  of induced sputum or 
samples  obtained  by  Broncho-Alveolar  Lavage  (BAL).  Trophozoits  and  intracystic 
sporozoits can be demonstrated in the  stained specimens.
Tuberculosis
One of the most common HIV-related OI is tuberculosis in the high prevalent 
areas.  HIV  increase  the  susceptibility  to  both  the  primary  infections  as  well  as  to 
reactivation of tuberculous-infection due to depressed cell-mediated immunity. 
Fever,  cough,  and weight  loss,  night  sweats  and malaise  are  common clinical 
findings. Fxtrapulmonary disease may involve other tissues and organs as the central 
nervous system, lymph nodes and mastoid. 
Problems  in  diagnosis  of  tuberculosis  occur  as  the  presentation  occurs  with 
unusual  features  and extrapulmonary  disease.  It  may  be  associated with a  negative 
tuberculin  test.  Careful  medical  history  with  emphasis  on  history  of  contact  with 
tuberculous  patient  is  important.  The  Mantoux  Test  is  considered   positive  if  the 
induration is 5 mm or more. The chest radiograph shows features of lobar or multi-lobar 
infiltrates or diffuses interstitial disease and hilar adenopathy. Isolation of the acidfast 
bacilli is the gold standard for diagnosis. 
Candida Infections
Severe oral candidiasis maybe that first clinical indication of HIV-Infection. Oral 
thrush and diaper dermatitis are common. Thrush is extensive and is relatively difficult 
to treat. Older children present with decreased oral intake and dysphagia, Esophageal 
candidiasis present with substernal or abdominal pain dysphagia and weight loss.
The lesions seen in oral candidiasis are typical and can be confirmed by observing 
pseudohyphae on a KOH-stained specimen. 
LAB DIAGNOSIS 
Test for HIV Infection
Ant- HIV antibody 
test Antigen detection
Virus isolation / 
Detection of viral 
nucleic acid
Screening:
Microwell  ELISA  test 
Rapid  tests.
P24 antigen assay Viral culture
Supplemental Tests:
Western blot 
Line immunoassay 
Recombinant  
     immunobloting assay
PCR tests (DNA / RNA)
Indications for ART
WHO 
Pediatric 
Stage
Availability of 
CD4 cell 
measurements
Age-specific treatment 
recommendation
<12 months ≥ 12 months
4a
CD4 Treat All
No CD4b
3a
CD4
No CD4
Treat All
Treat All, CD4 guided* 
in children with TB, LIP, 
OHL, Thrombocytopenia
Treat All
2
CD4 CD4 guided
No CD4 Do not treat
1
CD4 CD4 guided
No CD4 Do not treat
a. Stabilize any opportunistic infection prior to initiation of ARV Therapy.
b. Baseline CD4 is useful to monitor ART.
When to start ART in Children, agewise, using CD4 guidance*
< 11 months CD4 < 1500 cells/mm3 (<25%)
12-35 months CD4 < 750 cells/mm3 (<20%)
36-59 months CD4 < 350 cells/mm3 (<15%)
> 5 years old
Follow  adult  guidelines  i.e  start  ART  if 
CD4<350  cells/mm3 especially  if  symptomatic 
initiate before CD4 drops below 200 cells / mm3
OBSERVATIONS
 A Total number of 100 children affected by HIV infection were studied over a period 
of one year from October – 2007 – October 2008.
 There were 65 males and 35 females in the ratio of 185:1.
 22 Children were in the age group of <4 years and 78 children in the age group of 4 
to 12 years.
 Mother  to  child  transmission  accounted  for  the  highest  presumed  mode  of 
transmission 97 (97%). 
Two children  might  be  affected  due  to  Blood  transfusion  given during  Acute 
illness 2(2%).  
One child was infected by unidentified route.
 98 children were delivered by normal vaginal delivery, one child was delivered by 
emergency LSCS and for one child mode of delivery not known (Since she was an 
adopted child)
 Among Hundred children delivered, only one child received (? Neviripine) during 
peripartum period.
 49% of  children  received  Breast  milk  alone  for  first  4  month,  50% of  children 
received  both  Breast  milk  and  cow’s  milk  and  only  one  child  was  completely 
replaced milk substitute.
 Among 100 children who were infected by HIV infection
22% were asymptomatic
78% were symptomatic.
 Asymptomatic  children were identified during routine screening done,  as  their 
parents were found to be seropositive.
 Symptomatic children were divided into four groups based on the WHO clinical 
staging 2006 – Based on the nature of pathological status.
 Among symptomatic children, 
Stage I -  10
Stage II - 39
Stage III - 24
Stage IV - 5
CD4% was on the higher side in stage I and II diseases and it is lower for stage III 
and lowest in stage IV.
CD4 RANGE
Sl. No. Stages CD4 Range CD4 Ratio
1. Stage I 349 - 2263 18% - 35%
2. Stage II 304 -2083 7% - 29%
3. Stage III 81- 1277 7% - 32%
4. Stage IV 10 – 227 6% - 14.5%
The observed clinical features in the study subjects were : 
Skin lesions (23%), Neck swelling (17%), Respiratory symptoms and Recurrent 
RTI  (16%),  Oral  lesions  (10%),  Failure  to  the  (71%),  GI  symptoms (5%),  Chronic 
eardischarge (5%), Recurrent febrile illness (19%), and Neurological symptoms (4%).
Skin lesions alone present in (9%) and along with other symptoms in (14%).
The clinical sings were,
PEM (76%) Generalised lymphadenopathy (46%), Skin lesions (29%), Anaemia 
(16%),  Oral  lesions  (10%),  Anaemia  (16%),  Chronic  parotid  swelling  (2%),  CSOM 
(6%).
On systemic examination, 
Respiratory system involved in 14%.
Gastrointestinal system 3%
Central Nervous system 4%.
Lymphadenopathy is observed in (46%)
Generalised  significant  lymphadenopathy  alone  founding  12% of  patients.  TB 
lymphadenitis in 12% and lymphadenopathy with other clinical features in 22%.
CD4%  was  on  higher  side  average  being  >25%  in  patient  presented  with 
lymphadenitis and average being 12-14% in those who had lymphadenopathy along with 
other stage II, III and stage IV disease.
Skin lesions being the second common finding which were observed in 29% of patients.
Pruritic papular Eruption was the commonest clinical skin lesion noticed in 14 
children and the CD4% for this feature was ranging between (24-35%).
Scabies in 2 children, (CD4%, 12-20%) Molluscum in 1 (CD4 11%), Extensive 
impetigo in 2 (CD4 11%) Herpes in 3 (CD4 between 7-31%). These above mentioned 
four features were associated with low CD4 count compared to other features mentioned 
in the table.
Oral lesions were found in 10 children
Oral  candidiasis  was  observed  in  3  children  whose  CD4 range  was  between 
(8-10%),  leukoplakia  in  2  children  (CD4 25%).  Glossitis  and  Gingivostomatits  in  5 
children average CD4 count being 29% .
Chronic Suppurative Otitis Media
This was observed in 5% of children with CD4 count ranges between (7-19%).
Chronic parotid enlargement  noticed in two children with the CD4 count 25% and 
12%.
CLINICAL FEATURES
Clinical Features No. of Cases CD4 Ratio
Asymptomatic 22 18% - 35%
Lymphadenopathy  - 46 cases
Clinical Features No. of Cases CD4 Ratio
Lymphadenopathy alone 12 18% - 35%
Along with  other stage II 
and stage III clinical 
features 
22 7% - 29%
TB Lymphadenitis 12 11% - 32%
Skin Lesions – 29 cases  
Skin Lesions No. of Cases CD4%
Scabies 2 12%  - 20%
Eczema 4 20% - 24%
Molluscum 1 11%
Herpes 3 7-31%
Pruritic Papular eruptions 14 24-35%
Extensive impetigo 2 11%
Seborrhic dermatitis 3 22% - 24%
Oral lesions
Oral lesions No. of Cases Average CD4
Candidiasis 3 8-10%
Leukoplakia 2 25%
Glossitis 2 30%
Gingivostomatitis 3 28%
Among the opportunistic infection in these children
Pulmonary tuberculosis  was found in 13 cases,  Disseminated TB 2 cases,  TB 
Spine 1 case, TB meningitis 2 cases and TB lymphadenitis 12 cases. Thus Tuberculosis 
being the commonest opportunistic infection.
Oral candidiasis was observed in 3 cases with CD4 ranges between (8-10%) .
Pneumocystic carinii pneumonia (suspected) was observed in one child with CD4 
count (11%).
Opportunistic Infections
No. of Cases Average CD4
1. Pulmonary TB  12 cases
Pneumonia 10 7% - 31%
Empyema 1 17%
Bronchiectasis 2 7%, 16%
2. TB Spine 1 10%
3. Disseminated TB 2 9%, 11%
4. TBM 2 6%, 14.5%
5. Extrapulmonary TB 12 11% - 32%
6. PC Pneumonia (Suspected) 1 11%
On systemic examination in these children,
i) Respiratory system was involved most commonly (14 children) and TB pneumonia 
(Bronchopneumonia  –  6  cases,  Consolidation  –  4  cases)  was  most  common  (10 
children). CD4 count of,
 TB pneumonia with CD4 count between (6 – 31%)
 Empyema was observed in one child (CD4 17%)
 Bronchiectasis in 2 children  CD4 % (7% - 16%)
ii) Next was CNS involvement with CNS involvement with
 TB Meningitis 2 cases (CD4 % 6% - 14.5%)
 TB spine in 1 child (CD4 %   10%)
 HIV encephalopathy is child 9 (CD4 – 7)
iii) GI system was involved in 3 children
 Chronic diarrhecn in one child (CD4 %– 8%)
 Hepatosplenomegaly in two children (CD4 9% - 10%)
All the study group 100 children were classified as per IAP classification as below
Grade stage Io - 27%
Grade stage IIo - 24%
Grade stage IIIo -  16%
Grade stage IVo -  6%
Wt >80% as expected in 23%.
For height Mclaren’s classification was used and the various categories were observed 
as below.
<80% of expected Height (stunted) in 12%
80-93% expected Height (short stature) in 55 %
>93 % expected Height considered as normal in33%.
NUTRITIONAL STATUS
Wt: (against expected wt)
Weight (%) Stage I Stage II Stage III Stage IV
< 50% 0 0 5 1
50-60% 2 6 6 2
60-70% 9 9 5 1
70-80% 10 12 4 1
> 80% 9 9 5 -
Ht: (against expected Ht)
Height (%) Stage I Stage II Stage III Stage IV
< 80% 1 4 5 2
80-93% 19 18 15 3
> 93% 13 15 5 0
SUMMARY
100 children who were infected with HIV were taken as study group. Among 
them,
Asymptomatic were 22%
Symptomatic  were 78%
PEM observed in 76% cases and severe PEM was noticed (Grade III and IV and) 
in 22%.
Among  the  symptomatic  HIV  infected  children  the  clinical  feature  that  were 
observed,
Generalised lymphadenopathy – 46%
Lymphadenopathy alone observed in 10% with average CD4 count being 25%.
Lymphadenopathy associated with other features of stage II to IV HIV infection 
like pneumonia, skin lesions, oral lesions, severe PEM constitute about 26% and the 
average CD4 count in this group being 12-18%.
Generalised lymphadenopathy was the most common clinical manifestation in this 
study.
 Skin lesions were observed in 29% of children. Pruritic papular eruption being the 
common finding observed in 14 children with average CD4 % is bet (24 – 35%). 
Other lesions like scabies (CD4 11%), Herpes (CD4 7 – 31%) molluscum (CD4 11%). 
Extensive impetigo (CD4 11%) were also observed. These lesions were associates 
with low CD4 count.
 Among  oral  lesion  that  were  observed  oral  candidiasis  was  found   in  3%  and 
associated with low CD4 count (8-10%)
 Among  opportunistic  infections,  tuberculosis  was  found  to  be  the  commonest 
infection which was 30% (This include all forms of TB)
 Severe anemia (<8g%) was found in 16% which were predominantly in the children 
belong to stage III a stage IV illness, who were also associated with low CD4 count.
 As for  as  Nutritional  status in  concerned,  children in  stage  IV disease  belong to 
Grade III & IV PEM and height being <85% of the expected, where us, majority of 
stage I disease children have Grade IPEM.
 MTC transmission accounts for 97% and being the majority one.
 Only one was delivered by emergency LSCS and the rest were delivered  by normal 
vaginal delivery. For one child mode of delivery not known.
 Only one child was replaced with milk substitute and given neviripine ?  perinatally. 
Rest of the children were given either Breast milk or mixed (both BF & Cow’s milk) 
not received Neviripine. 
 Since  children  infected  with  HIV  having,  Asymptomatic  generalised 
lympadenopathy,  skin lesions like eczema,  pruritic  papular  eruptions,  oral  lesions 
like  glossitis  and  gingivostomatitis  were  associated  with  the  high  CD4  count, 
intensifying  the  screening  for  HIV  infection  by  high  suspicion  will  help  in 
diagnosing HIV infected children at the earliest, and thus they can be subjected to 
early  management  and  follow  up  periodically.  Early  management  include  – 
chemoprophylaxis, immunization, management of opportunistic infection, nutritional 
support and ARV Therapy.
 Proper ART to AN mother who were identified as HIV infected, ART to mother and 
baby  during  peripartum  period,  Elective  LSCS,  proper  milk  substitution  will 
definitely found to be effective in reducing  MTC transmission.
LIMITATIONS
 In this study mostly we have observed clinical features of slow progressors and 
since  children  <  18  months  were  not  included  clinical  manifestation  of  rapid 
progressors could not be identified.
 Diagnosis of PCP in one child was made on the basis of clinical features and a 
CXR finding. This was not confirmed by BAL / Biopsy. 
 Investigations to identify CMV, toxoplasmosis, hepatitis infection were not done.
LITERATURE REVIEW
When we go through the various literature on the various Indian and non-Indian 
studies on the clinical profile of paediatric HIV, this study has some similarities and few 
differences from them.
As is all previous studies,
 Perinatal transmission was the most common mode of transmission in this study.
 Dermatological manifestation and generalized lympadenopathy were the frequent 
manifestation among the  HIV infield children.
 Tuberculosis  was  found  to  be  the  commonest  opportunistic  infection  in  our 
country and this study also reflected that.
 Severe PEM (III & IV) was found in significant percentage in severe form of HIV 
infection.
 Hepatosplenomegnly  was  less  in  number  compared  to  various  Indian  & non-
Indian studies. 
 Comparison of  clinical  profile  of  our  study  done with  other  Indian and Non-
Indian studies given in the following tables.
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CLINICAL PROFILE OF HIV IN PAEDIATRIC AGE GROUP 
FROM 18 MONTHS TO 12 YEARS AND TO CORRELATE 
WITH CD4 COUNT
Name : Weight :
Age / Sex : Height :
Address :
Complaints :
Yes No
Fever
Cough
Diarrhea
FTT
Oral ulcers
Skin rash
Breathlessness
Seizures
Swelling in neck/axilla
None
Complaints :
Yes No
Oral Candidiasis
Chronic diarrhea
Recurrent RTI
Herpes Zoster
Blood transfusion
Seizures
Jaundice
Unsafe injection/surgery
Recurrent Febrile Episodes
None
Birth History:
Normal Caesarean Vaccum Forceps
Birth Weight
Neviripine
Feeding
Breast Milk Replacement Mixed
Development
Normal Abnormal
Examination :
Nutrition Normal Abnormal
Yes No
Anaemia
Cyanosis
Fever
Tachypnoea
Jaundice
Pedal edema
Lymph nodes
Matted Discrete
Cervical Axillary Others
Skin Lesions:
TBA Scabres Herpes zoster
Seborrhic dermatitis taeniasis Warts
Oral Vacity
Normal Abnormal (specify)
Parotid Swelling
Ear dischife
Petrechi / Purpura
Systemic Examination:
Abdomen
Normal Abnormal
Respiratory Space
Normal Abnormal
Cardiovascular System
Normal Abnormal
Central nervous system
Normal Abnormal
Investigations
Diagnosis :
HIV Status : Symptomatic Asymptomatic
WHO Clinical State : I II III IV
Parental Status :  Father Mother  
Sibling
Occupation :
Socio Economic Status :
CD4 Count :
Treatment :

